Friday, 18 May 2012 | Source: The Associated Press
Shares of medical test maker Sequenom fell Friday, a day after the company announced that insurer Coventry Health Care Inc. would no longer pay for the company's Down syndrome test for pregnant women.
Information technology and healthcare are two sectors where investors can find value, Peter Garnry, equity strategist at Saxo Bank told CNBC.... Read More